Latest news
The EMERALD study
Trial status: active not recruiting
Trial ID: NCT06823713
What is the EMERALD study?
EMERALD is a clinical trial designed to test if a new treatment called RTX001 is safe, easy to cope with, and works well for people suffering ...
Liver UK launches in Westminster to put liver disease on the political agenda
Liver UK, the new name for the British Liver Trust and Children’s Liver Disease Foundation, has officially launched in Westminster with a clear message to parliamentarians -- liver disease is rising, largely preventable, and demands ...
People in the UK fear cancer and heart disease – but overlook one of the biggest killers of working-age adults
New data released today has revealed that just 9% of people actively think about or monitor their liver health despite liver disease being one of the leading causes of premature death among working-age adults.
Liver disease is ...
A new chapter for liver health: together we are Liver UK
Today, we take the next step in that journey as Liver UK: a stronger, clearer and more united voice for liver health.
Potential for hundreds more liver transplants after NICE recommends new life-saving liver procedure for NHS use
The British Liver Trust welcomes the news that hundreds more liver transplants could be carried out after a new procedure that supplies a donor liver with oxygen before removal was approved by NICE for use in the NHS.
In-situ ...
New hope for people living with MASH as two treatments receive MHRA approval
People living with metabolic dysfunction-associated steatohepatitis (MASH) have received encouraging news, with the UK medicines regulator approving two treatments for the condition within the past month. The Medicines and Healthcare ...
New Lancet Commission Highlights the Vital Role of Primary Care in Tackling Liver Disease
A major new Lancet Gastroenterology & Hepatology Commission, published today, has shone a spotlight on the crucial role that primary care can play in preventing, detecting and managing liver disease. We were proud to contribute to ...
Free and confidential support service for people affected by contaminated blood
The Infected Blood Psychological Service (IBPS) is offering free and confidential support to anyone living in England who has been infected with contaminated blood and their loved ones.
The service offers people the space to talk ...
The MATCH trial – testing Macrophage cells to treat liver cirrhosis
This page is a summary of the MATCH trial. The trial looked at the possibility of using a type of white blood cell called a macrophage to treat liver cirrhosis.
What are macrophages?
We have lots of different types of white blood ...
The OPAL study
Trial status: Active, not recruiting
Trial ID: NCT06380335
What is OPAL?
OPAL is an observational study sponsored by Resolution Therapeutics. 11 hospitals across England and Scotland are participating in the study.
OPAL ...
We welcome the launch of the world’s first WHO Collaborating Centre dedicated to liver disease
The World Health Organization (WHO) Regional Office for Europe, Imperial College London and the European Association for the Study of the Liver (EASL) today inaugurate the first WHO Collaborating Centre dedicated to liver disease, at ...
1,000ft-high wing walk is a breeze for thrill-seeker Tracy
Being strapped to the top of a plane and flying at 120mph at 1,000ft isn’t what most people with a fear of heights would do for fun, but Tracy Ross from Helensburgh isn’t most people.
The 51-year-old thrill-seeker recently did a ...
No results found.
More from Liver UK
Check your risk
Find out if you’re at risk of liver disease using our simple at-risk checker for adults.
Find out more
Support us
Make a donation to help ensure everyone affected by liver disease gets the information and support they need.
Find out more
Keep up to date
Keep up to date with the charity’s news by registering for our email newsletter & updates.
Find out more
No results found.